Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 990 across all filing types
Latest filing 2025-08-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
中小投资者单独计票管理办法
Governance Information Classification · 95% confidence The document is a detailed procedural guideline titled '中小投资者单独计票管理办法' (Management Measures for Separate Voting of Minority Investors) issued by Zhejiang Tailin Biotechnology Co., Ltd. It outlines rules and procedures for separate vote counting for minority shareholders during shareholder meetings, including voting scope, procedures, and disclosure requirements. The content focuses on governance practices related to shareholder voting rights and protections for minority investors, referencing regulatory bodies like the China Securities Regulatory Commission and Shenzhen Stock Exchange. It is not a financial report, earnings release, or announcement of voting results but a governance-related policy document. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2029 characters, which is relatively short but contains substantive governance rules rather than a mere announcement or notice, so it is not RPA or RNS.
2025-08-28 Chinese
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled as an "Investor Relations Management System" for Zhejiang Tailin Biotechnology Co., Ltd. It outlines policies, principles, and procedures for managing investor relations, including communication with investors, disclosure obligations, and governance of investor relations activities. It does not contain financial statements, earnings data, or audit information. It is a governance-related document focused on investor relations management practices and compliance with regulatory requirements. Therefore, it fits best under Governance Information (CGR) as it details internal rules and governance practices related to investor relations management.
2025-08-28 Chinese
内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system for insider information registration and confidentiality at Zhejiang Tailin Biotechnology Co., Ltd. It outlines the company's policies, procedures, and responsibilities related to insider information, including definitions, scope, registration, confidentiality, and penalties. It references relevant laws and regulatory bodies such as the China Securities Regulatory Commission and Shenzhen Stock Exchange. The document is a regulatory compliance and governance document rather than a financial report, earnings release, or announcement. It does not contain financial statements, earnings data, or voting results. It is not a report publication announcement or a certification. Therefore, it best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-08-28 Chinese
内部控制制度
Governance Information Classification · 95% confidence The document is titled '内部控制制度' (Internal Control System) of Zhejiang Tailin Biotechnology Co., Ltd. It details the company's internal control policies, governance structure, risk management, and procedures for related party transactions, external guarantees, major investments, information disclosure, and subsidiary management. It references compliance with laws, regulations, and Shenzhen Stock Exchange rules. The document is comprehensive and contains detailed internal control policies rather than being an announcement or a brief summary. It does not contain financial statements or quarterly results, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a certification or a short announcement, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA). The content focuses on governance and internal control practices, which aligns with Governance Information (CGR). Therefore, the document is best classified as Governance Information (CGR).
2025-08-28 Chinese
独立董事专门会议工作制度
Governance Information Classification · 95% confidence The document is titled as a working system for the Independent Directors' Special Meeting of Zhejiang Tailin Biotechnology Co., Ltd. It details governance procedures, meeting rules, voting, and duties of independent directors. It references company law, securities regulations, and internal company bylaws. There is no financial data, no report or results, no announcement of voting results, no executive changes, no earnings or capital updates, and no legal proceedings. The document is a governance-related internal rules document focused on board structure and director duties. Therefore, it fits best under Governance Information (CGR). The document length is 2384 characters, which is consistent with a detailed governance policy rather than a brief announcement or a full annual report.
2025-08-28 Chinese
董事会战略委员会工作细则
Governance Information Classification · 95% confidence The document is a detailed set of rules and procedures for the Board's Strategic Committee, including its responsibilities, organization, decision-making processes, and governance. It is a governance-related document outlining internal board committee rules rather than a financial report, announcement, or regulatory filing. There is no indication of financial data, voting results, or report publication. The content fits the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2025-08-28 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.